RADFORSK INVESTERINGSSTIFTELSE

Radforsk is an early stage Evergreen Fund dedicated to oncology, and one of the most successful pre-seed investment firms in Europe.

Keywords

civic initiativesprotest movementsenvironmental movementsecological movementsminority groupspatrioticassociationswar veteransconsumer organizationsautomobile associationsrotary clubslodgesyouth organizationsstudent associationsclubs and fraternitiesliterary associationshistorical associationsgarden societiesfilm clubsphotography clubsmusic associationsart associationscraft associationsstamp clubs

Organization

CEO: JE
Jónas Einarsson1957
Chairman of the board: HG
Hanne Gaaserød1962
Years since formation: 30 years; since Feb 19, 1995
Type: Foundation
VAT registered: Yes
Number of employees: 5

Financials

Total operating income 2024: 5,374,000; NOK
Annual total result 2024: -615,650,000; NOK
Total equity 2024: 81,697,000; NOK

Last update: Sep 9, 2025

Management

Management / administration

Name	Role	Shares
JE Jónas Einarsson 1957	Managing Director/CEO	-

Board

Name	Role	Shares
IS Inger Sandlie 1953	Board Member	-
EB Erlend Bremertun Smeland 1955	Board Member	-
HG Hanne Gaaserød 1962	Chairman	-
JJ Jørgen Jansen 1965	Board Member	-
AM Anne Merete Sveaass 1981	Board Member	-

Others

Name	Role	Shares
K KPMG AS	Auditor	-

Last update: Mar 28, 2025

Ownership

Shares owned by the RADFORSK INVESTERINGSSTIFTELSE

Name	Share class	Total number of shares	Share
S SRB RADIOPHARMA HOLDING AS	Ordinary shares	105,864	35.29 %
B BIOMOLEX AS	NO0010162266	168,863	20.3 %
N NEXTERA AS	NO0010848534	791,184	19.32 %
Z ZELLUNA IMMUNOTHERAPY AS	NO0010820731	1,834,205	14.97 %
H HUBRO THERAPEUTICS AS	NO0012442260	245,417	5.93 %
O OSLO CANCER CLUSTER INCUBATOR AS	Ordinary shares	13,533	5.83 %
Z ZELLUNA ASA	NO0010851603	1,519,263	4.42 %
N NYKODE THERAPEUTICS ASA	NO0010714785	10,315,311	3.16 %
A ADJUTEC PHARMA AS	Ordinary shares	837	1.71 %
O ONCOINVENT ASA	NO0010779341	651,110	0.71 %
L LEDIDI AS	Ordinary shares	4,300	0.25 %
P PCI BIOTECH HOLDING ASA	NO0010405640	70,664	0.19 %
S SERODUS AS	NO0010549801	1	< 0.01 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	5,374,000	4,252,000	7,447,000	6,697,000
Annual Total Result	-615,650,000	-181,992,000	589,561,000	-21,912,000
Total assets	117,976,000	849,040,000	1,012,759,000	386,393,000
Total liabilities	36,279,000	151,693,000	133,421,000	96,617,000
Total equity	81,697,000	697,347,000	879,338,000	289,776,000

P&L

Year	2024	2023	2022	2021
Total operating income	5,374,000	4,252,000	7,447,000	6,697,000
Total operating costs	16,699,000	18,760,000	18,198,000	26,571,000
Operating result	-11,325,000	-14,508,000	-10,751,000	-19,874,000
Financial income/costs	-604,325,000	-167,484,000	600,312,000	-2,038,000
Profit before tax	-615,650,000	-181,992,000	589,561,000	-21,912,000
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-615,650,000	-181,992,000	589,561,000	-21,912,000

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	139,000	139,000	139,000	139,000
Total current assets	117,837,000	848,901,000	1,012,620,000	386,254,000
Total assets	117,976,000	849,040,000	1,012,759,000	386,393,000
Short term debt	14,345,000	25,774,000	24,108,000	28,617,000
Long term debt	21,934,000	125,920,000	109,313,000	68,000,000
Total liabilities	36,279,000	151,693,000	133,421,000	96,617,000
Contributed capital	1,000,000	1,000,000	1,000,000	1,000,000
Retained earnings	80,697,000	696,347,000	878,338,000	288,776,000
Total equity	81,697,000	697,347,000	879,338,000	289,776,000
Total equity and liabilities	117,976,000	849,040,000	1,012,759,000	386,393,000

RADFORSK INVESTERINGSSTIFTELSE952 715 704